The Valley Desk

Clinical trial reportJournal of neurologyPublished

Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of neurology
Published
Subject terms
Humans; Multiple Sclerosis, Relapsing-Remitting; Toluidines; Crotonates; Hydroxybutyrates; Benzylidene Compounds; Nitriles; Thiazoles; Treatment Outcome; Adult; Middle Aged; Female
PubMed ID
41879928
PubMed Central ID
PMC13018072
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal